Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hemolytic anemia is a forme fruste of
systemic lupus erythematosus
(
SLE
), being observed months or even years before the onset of other clinical manifestations in some patients. We hypothesized that hemolytic anemia in those
SLE
-affected patients would identify a group of
SLE
pedigrees that share a high degree of genetic homogeneity. From 160 multiplex
SLE
pedigrees, we sought evidence for linkage in 35 (16 African-American, 17 European-American, and 2 Hispanic) who had at least one
SLE
-affected patient with hemolytic anemia. Significant linkage was present at 11q14 in the 16 African-American pedigrees, yielding a maximum two-point logarithm of odds (LOD) score of 4.5 at D11S2002. The segregation pattern of
SLE
in these African-American pedigrees suggested a dominant mode of inheritance and, when maximized across penetrance and disease allele frequencies, produced a multipoint LOD of 4.7. Multipoint analysis yielded a multipoint heterogeneity LOD score of 3.6 (alpha = 0.63), again with maximum LOD at D11S2002. Finally, markers typed 7 centimorgans to either side of D11S2002 achieved LOD scores of 3 or better by using the maximized model, supporting linkage to 11q14. Clearly, pedigree ascertainment based on select clinical manifestations is an important tool, capable of revealing otherwise cryptic genetic linkages in complex genetic diseases. Thus, we show strong evidence for an
SLE
susceptibility gene,
SLEH1
, near D11S2002 in African-American pedigrees multiplex for
SLE
that have at least one
SLE
-affected patient with hemolytic anemia.
...
PMID:Evidence for a susceptibility gene (SLEH1) on chromosome 11q14 for systemic lupus erythematosus (SLE) families with hemolytic anemia. 1219 84
Systemic lupus erythematosus
(
SLE
) is an autoimmune disease with complex genetics. We evaluated pedigrees multiplex for
SLE
that had an affected with antinucleolar antibodies to increase the homogeneity for genetic linkage analysis. We found a significant linkage effect on chromosome 11q14 at marker D11S2002 in African-American Pedigrees. This effect produced a maximum LOD score of 5.62 using a dominant inheritance model with 95% penetrance in males and 99% penetrance in females. The results were supported by multipoint linkage analysis. Fine mapping of the region with two additional markers within 6 cM of D11S2002 further provided evidence of linkage in this region. Linkage at D11S2002, named
SLEH1
, was previously found in some of these same African-American pedigrees multiplex for
SLE
, but who were stratified by hemolytic anemia (Kelly et al, submitted). In conclusion, an important
SLE
susceptibility gene,
SLEH1
at 11q14, is identified in African-Americans when stratifying pedigrees by antinucleolar autoantibodies.
...
PMID:Genetic linkage of systemic lupus erythematosus with chromosome 11q14 (SLEH1) in African-American families stratified by a nucleolar antinuclear antibody pattern. 1221 99